본문 바로가기
KERD
논문KCI 등재

Advances in Systems Biology Approaches for Autoimmune Diseases

이상헌|김해림|김호연
대한면역학회 (The Korean Association of Immunologists)|2014.04|Immune Network|제14권 제2호|pp. 73-80

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Network analysisSystems biologyBiomarkerAutoimmune diseasesMulti-omicsTranslational research

초록

Because autoimmune diseases (AIDs) result from a complex combination of genetic and epigenetic factors, as well as an altered immune response to endogenous or exogenous antigens, systems biology approaches have been widely applied. The use of multi-omics approaches, including blood transcriptomics, genomics, epigenetics, proteomics, and metabolomics, not only allow for the discovery of a number of biomarkers but also will provide new directions for further translational AIDs applications. Systems biology approaches rely on high-throughput techniques with data analysis platforms that leverage the assessment of genes, proteins, metabolites, and network analysis of complex biologic or pathways implicated in specific AID conditions. To facilitate the discovery of validated and qualified biomarkers, better-coordinated multi-omics approaches and standardized translational research, in combination with the skills of biologists, clinicians, engineers, and bioinformaticians, are required.

Abstract

Because autoimmune diseases (AIDs) result from a complex combination of genetic and epigenetic factors, as well as an altered immune response to endogenous or exogenous antigens, systems biology approaches have been widely applied. The use of multi-omics approaches, including blood transcriptomics, genomics, epigenetics, proteomics, and metabolomics, not only allow for the discovery of a number of biomarkers but also will provide new directions for further translational AIDs applications. Systems biology approaches rely on high-throughput techniques with data analysis platforms that leverage the assessment of genes, proteins, metabolites, and network analysis of complex biologic or pathways implicated in specific AID conditions. To facilitate the discovery of validated and qualified biomarkers, better-coordinated multi-omics approaches and standardized translational research, in combination with the skills of biologists, clinicians, engineers, and bioinformaticians, are required.

참고문헌 (56)

  1. Whitacre, C. C., "Sex differences in autoimmune disease", Nat. Immunol, 2, pp.777~780 (2001)
  2. Blumberg, R. S., "Unraveling the autoimmune translational research process layer by layer", Nat. Med, 18, pp.35~41 (2012)
  3. Goldblatt, F, "Clinical aspects of autoimmune rheumatic diseases", Lancet, 382, pp.797~808 (2013)
  4. Trowsdale, J., "The MHC, disease and selection", Immunol. Lett, 137, pp.1~8 (2011)
  5. Nocturne, G, "Advances in understanding the pathogenesis of primary Sjogren's syndrome", Nat. Rev. Rheumatol, 9, pp.544~556 (2013)
  6. Harley, J. B., "A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease", Arthritis Rheum, 32, pp.826~836 (1989)
  7. Lessard, C. J., "Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome", Nat. Genet, 45, pp.1284~1292 (2013)
  8. Viatte, S., "Genetics and epigenetics of rheumatoid arthritis", Nat. Rev. Rheumatol, 9, pp.141~153 (2013)
  9. Zhebrun, D., "Association of PTPN22 1858T", T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population, 2011, pp.3, 368~373
  10. Hewagama, A., "The genetics and epigenetics of autoimmune diseases", J. Autoimmun, 33, pp.3~11 (2009)
  11. Franke, A., "Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci", Nat. Genet, 42, pp.1118~1125 (2010)
  12. Oksenberg, J. R., "The genetics of multiple sclerosis: SNPs to pathways to pathogenesis", Nat. Rev. Genet, 9, pp.516~526 (2008)
  13. Duffin, K. C., "Genetics of psoriasis and psoriatic arthritis: update and future direction", J. Rheumatol, 35, pp.1449~1453 (2008)
  14. Stahl, E. A., "Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci", Nat. Genet, 42, pp.508~514 (2010)
  15. Zhernakova, A., "Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci", PLoS Genet, 7, pp.e1002004~ (2011)
  16. Han, J. W., "Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus", Nat. Genet, 41, pp.1234~1237 (2009)
  17. Barrett, J. C., "Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes", Nat. Genet, 41, pp.703~707 (2009)
  18. Hu, X., "Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets", Am. J. Hum. Genet, 89, pp.496~506 (2011)
  19. Ermann, J, "Autoimmune diseases: genes, bugs and failed regulation", Nat. Immunol, 2, pp.759~761 (2001)
  20. Jaenisch, R., "Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals", Nat. Genet, 33(Suppl), pp.245~254 (2003)
  21. Jirtle, R. L, "Environmental epigenomics and disease susceptibility", Nat. Rev. Genet, 8, pp.253~262 (2007)
  22. Portela, A., "Epigenetic modifications and human disease", Nat. Biotechnol, 28, pp.1057~1068 (2010)
  23. Sekigawa, I., "DNA methylation: its contribution to systemic lupus erythematosus", Clin. Exp. Med, 6, pp.99~106 (2006)
  24. Quintero-Ronderos, P, "Epigenetics and autoimmune diseases", Autoimmune Dis, 2012, pp.593720~ (2012)
  25. Pauley, K. M., "MicroRNA in autoimmunity and autoimmune diseases", J. Autoimmun, 32, pp.189~194 (2009)
  26. Pascual, V., "A genomic approach to human autoimmune diseases", Annu. Rev. Immunol, 28, pp.535~571 (2010)
  27. Blanco, P., "Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus", Science, 294, pp.1540~1543 (2001)
  28. Shodell, M., "Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration", Lupus, 12, pp.222~230 (2003)
  29. Bennett, L., "Interferon and granulopoiesis signatures in systemic lupus erythematosus blood", J. Exp. Med, 197, pp.711~723 (2003)
  30. Vincent, F. B., "Clinical associations of serum interleukin-17 in systemic lupus erythematosus", Arthritis Res. Ther, 15, pp.R97~ (2013)
  31. Krausgruber, T., "IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses", Nat. Iimmunol, 12, pp.231~238 (2011)
  32. Banchereau, J., "Type I interferon in systemic lupus erythematosus and other autoimmune diseases", Immunity, 25, pp.383~392 (2006)
  33. Nikula, T., "Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood", Transl. Res, 161, pp.181~188 (2013)
  34. Chiche, L., "Current perspectives on systems immunology approaches to rheumatic diseases", Arthritis Rheum, 65, pp.1407~1417 (2013)
  35. Croze, E., "Differential gene expression and translational approaches to identify biomarkers of interferon beta activity in multiple sclerosis", J. Interferon Cytokine Res, 30, pp.743~749 (2010)
  36. Mohr, S., "The peripheral-blood transcriptome: new insights into disease and risk assessment", Trends Mol. Med, 13, pp.422~432 (2007)
  37. Robinson, W. H., "Proteomics technologies for the study of autoimmune disease", Arthritis Rheum, 46, pp.885~893 (2002)
  38. Baechler, E. C., "Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus", Proc. Natl. Acad. Sci. USA, 100, pp.2610~2615 (2003)
  39. Pascual, V., "The central role of dendritic cells and interferon-alpha in SLE", Curr. Opin. Rheumatol, 15, pp.548~556 (2003)
  40. Sigurdsson, S., "A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5", Hum. Mol. Genet, 17, pp.2868~2876 (2008)
  41. Remmers, E. F., "STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus", N. Engl. J. Med, 357, pp.977~986 (2007)
  42. Elkon, K. B., "Type I interferon and systemic lupus erythematosus", J. Interferon Cytokine Res, 31, pp.803~812 (2011)
  43. Stetson, D. B., "Trex1 prevents cell-intrinsic initiation of autoimmunity", Cell, 134, pp.587~598 (2008)
  44. Bauer, J. W., "Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study", Arthritis Rheum, 60, pp.3098~3107 (2009)
  45. Tektonidou, M. G., "Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases", Arthritis Res. Ther, 12, pp.R179~ (2010)
  46. Kussmann, M., "OMICS-driven biomarker discovery in nutrition and health", J. Biotechnol, 124, pp.758~787 (2006)
  47. Plebani, M., "Recent advances in diagnostic technologies for autoimmune diseases", Autoimmun. Rev, 8, pp.238~243 (2009)
  48. Kussmann, M., "OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers", Endocr. Metab. Immune Disord. Drug Targets, 7, pp.271~287 (2007)
  49. Delaleu, N., "Biomarker profiles in serum and saliva of experimental Sjogren's syndrome: associations with specific autoimmune manifestations", Arthritis Res. Ther, 10, pp.R22~ (2008)
  50. Schweitzer, B., "Microarrays to characterize protein interactions on a whole-proteome scale", Proteomics, 3, pp.2190~2199 (2003)
  51. Ciofani, M., "A validated regulatory network for Th17 cell specification", Cell, 151, pp.289~303 (2012)
  52. Ivanov, I. I., "Transcriptional regulation of Th17 cell differentiation", Semin. Immunol, 19, pp.409~417 (2007)
  53. Yosef, N., "Dynamic regulatory network controlling TH17 cell differentiation", Nature, 496, pp.461~468 (2013)
  54. Solt, L. A., "Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand", Nature, 472, pp.491~494 (2011)
  55. Kitteringham, N. R., "Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci, 877, pp.1229~1239 (2009)
  56. Ghosh, D, ""Omics" data and levels of evidence for biomarker discovery", Genomics, 93, pp.13~16 (2009)

관련 논문AI추천

Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases신옥, 오수진, 최영기연세대학교의과대학 · Yonsei Medical Journal2018 · 제59권 제2호Proteomics in Rheumatoid Arthritis Research김완욱, 박윤정, 정민경, 황대희대한면역학회 · Immune Network2015 · 제15권 제4호MicroRNA Regulation in Systemic Lupus Erythematosus PathogenesisChak Sing Lau, Liwei Lu, Lok Yan Yim, Sheng Yan, Vera Sau-Fong Chan대한면역학회 · Immune Network2014 · 제14권 제3호Potential Implications of Long Noncoding RNAs in Autoimmune Diseases허근, 김상현, 김지민대한면역학회 · Immune Network2019 · 제19권 제1호Targeted Immunotherapy for Autoimmune Disease김완욱, 정승민대한면역학회 · Immune Network2022 · 제22권 제1호Network Analysis in Systems Epidemiology박주용, 최지엽, Choi Jaesung대한예방의학회 · 예방의학회지2021 · 제54권 제4호

이 간행물의 다른 논문 (6건)

HVEM is a TNF Receptor with Multiple Regulatory Roles in the Mucosal Immune SystemJr-Wen Shui, Mitchell Kronenbergpp. 67-72Preclinical Efficacy and Mechanisms of Mesenchymal Stem Cells in Animal Models of Autoimmune DiseasesIn Sung Chung, Yunsoo Park, Mi Jeong Park, Yong Guk Kim, Jin Tae HONG, 이홍경, Ju Young Kim, 한상배, 김영수, Sang Hee Limpp. 81-88Kinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease주지민, 최은영, 이동섭, 이학모, 오근희pp. 89-99Shigella flexneri Inhibits Intestinal Inflammation by Modulation of Host Sphingosine-1-Phosphate in Mice김영인, 권미나, 장선영, 고현정, 양진영pp. 100-106Phellinus linteus Extract Exerts Anti-asthmatic Effects by Suppressing NF-κB and p38 MAPK Activity in an OVA-induced Mouse Model of AsthmaGuang-Hai Yan, 최윤호pp. 107-115
원문 보기